Source:http://linkedlifedata.com/resource/pubmed/id/20712893
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2010-9-6
|
pubmed:abstractText |
X-linked inhibitor of apoptosis protein (XIAP) is often overexpressed in cancer cells, where it plays a key role in survival and also promotes invasiveness. To date however, the extracellular signals and intracellular pathways regulating its expression and activity remain incompletely understood. We have previously showed that exposure to each of the three TGF-beta (transforming growth factor beta) isoforms upregulates XIAP protein content in endometrial carcinoma cells in vitro. In the present study, we have investigated the clinical relevance of TGF-beta isoforms in endometrial tumours and the mechanisms through which TGF-beta isoforms regulate XIAP content in uterine cancer cells.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta,
http://linkedlifedata.com/resource/pubmed/chemical/X-Linked Inhibitor of Apoptosis...,
http://linkedlifedata.com/resource/pubmed/chemical/XIAP protein, human
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1476-4598
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
216
|
pubmed:meshHeading |
pubmed-meshheading:20712893-Cell Line, Tumor,
pubmed-meshheading:20712893-Gene Expression Regulation,
pubmed-meshheading:20712893-Humans,
pubmed-meshheading:20712893-RNA, Messenger,
pubmed-meshheading:20712893-Signal Transduction,
pubmed-meshheading:20712893-Transforming Growth Factor beta,
pubmed-meshheading:20712893-X-Linked Inhibitor of Apoptosis Protein
|
pubmed:year |
2010
|
pubmed:articleTitle |
XIAP gene expression and function is regulated by autocrine and paracrine TGF-beta signaling.
|
pubmed:affiliation |
Research group in Molecular Oncology and Endocrinology, Department of Chemistry-Biology, University of Quebec at Trois-Rivieres, Trois-Rivières, Quebec, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|